QC
BIOA

Quadrature Capital’s BioAge Labs BIOA Stock Holding History

Quadrature Capital’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$232K Buy
+9,480
New +$171K ﹤0.01% 1307
2026
Q1 		– Sell
-16,769
Closed -$222K – 1949
2025
Q4 		$222K Buy
16,769
+6,035
+56% +$53.5K ﹤0.01% 945
2025
Q3 		$63.1K Buy
+10,734
New +$50.3K ﹤0.01% 939

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

Quadrature Capital's BIOA Position: Q2 2026 in Review

Quadrature Capital opened a new position in BioAge Labs (BIOA) in Q2 2026: 9,480 shares worth $232K. The stake represents ﹤0.01% of the portfolio and ranks #1307 among its holdings. This is a return to the name: Quadrature Capital previously reported a position in BIOA as recently as Q4 2025.

Quadrature Capital first reported a position in BIOA in Q3 2025 and has held it in 3 quarters since. 151 funds tracked by Wall St. Rank hold BIOA as of Q2 2026.

  • Quadrature Capital held 9,480 shares of BioAge Labs worth $232K as of Q2 2026.
  • BioAge Labs was a new Quadrature Capital position in Q2 2026.
  • BioAge Labs made up ﹤0.01% of Quadrature Capital's portfolio in Q2 2026, its #1307 holding.
  • Quadrature Capital first reported a position in BioAge Labs in Q3 2025 and has held it in 3 quarters since.
  • 151 funds tracked by Wall St. Rank held BioAge Labs as of Q2 2026.

Based on Quadrature Capital's 13F filing for Q2 2026, filed 7 Aug 2026.